Biorithm has developed a remote maternal-fetal care platform to deliver home care for pregnant and postnatal patients.
Biorithm has raised $3.5M in total funding. The most recent round was Series A. The last funding was announced in December 2023.
Biorithm's investors include Australian Medical Angels, Seeds Capital, Adaptive Capital Partners, AIA Konica Minolta Digital Health Accelerator.
Biorithm is headquartered in Singapore, Singapore.
Biorithm has developed a remote maternal-fetal care platform to deliver home care for pregnant and postnatal patients.
Biorithm is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biorithm — Funding & Investors." VCBacked, December 18, 2023, https://www.vcbacked.co/company/biorithm. Accessed September 14, 2026.
VCBacked. (2023). Biorithm — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/biorithm
{{cite web |title=Biorithm — Funding & Investors |url=https://www.vcbacked.co/company/biorithm |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated